We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+9.64%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.3B
AUM Growth
+$1.22B
(+4.7%)
Cap. Flow
-$932M
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
60.57%
Holding
1,588
New
70
Increased
176
Reduced
495
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$128M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$67.4M |
| 3 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$63.8M |
| 4 |
UnitedHealth
UNH
|
+$57.4M |
| 5 |
Danaher
DHR
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$760M |
| 2 |
Amazon
AMZN
|
+$68.5M |
| 3 |
AbbVie
ABBV
|
+$54.2M |
| 4 |
PPLI
People Inc
PPLI
|
+$36.8M |
| 5 |
PNC Financial Services
PNC
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 44.09% |
| 2 | Technology | 18.28% |
| 3 | Healthcare | 10.34% |
| 4 | Consumer Discretionary | 7.89% |
| 5 | Communication Services | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
FedEx
FDX
$75.3B
| $2.33M | 0.01% |
9,403
-134
| -1% | -$30.7K |
|
277
Roper Technologies
ROP
$36.7B
| $2.32M | 0.01% |
4,828
+20
| +0.4% | +$9.06K |
|
278
SEACOR Marine Holdings
SMHI
$214M
| $2.31M | 0.01% |
202,475
-26,615
| -12% | -$236K |
|
279
Chemung Financial Corp
CHMG
$383M
| $2.29M | 0.01% |
59,618
| – | – |
|
280
Allstate
ALL
$67B
| $2.26M | 0.01% |
20,683
| – | – |
|
281
Vanguard Total Stock Market ETF
VTI
$658B
| $2.24M | 0.01% |
10,173
-2,341
| -19% | -$488K |
|
282
Amdocs
DOX
$5.58B
| $2.24M | 0.01% |
22,664
| – | – |
|
|
AMAM
283
DELISTED
Ambrx Biopharma Inc
AMAM
| $2.22M | 0.01% |
+135,003
| New | +$1.7M |
|
284
Unitil
UTL
$1B
| $2.22M | 0.01% |
43,805
-860
| -2% | -$47.7K |
|
285
Huntington Bancshares
HBAN
$35.1B
| $2.22M | 0.01% |
206,037
-25,699
| -11% | -$275K |
|
286
Sysco
SYY
$39.8B
| $2.21M | 0.01% |
29,833
-2,730
| -8% | -$202K |
|
287
Mid-America Apartment Communities
MAA
$15.6B
| $2.16M | 0.01% |
14,207
-500
| -3% | -$75.1K |
|
288
MGM Resorts International
MGM
$11.9B
| $2.14M | 0.01% |
48,836
-908
| -2% | -$38.8K |
|
289
RLX Technology
RLX
$2.52B
| $2.12M | 0.01% |
1,200,000
| – | – |
|
290
Mueller Water Products
MWA
$3.96B
| $2.1M | 0.01% |
129,295
-42,130
| -25% | -$599K |
|
291
Knife River
KNF
$4.5B
| $2.09M | 0.01% |
+48,026
| New | +$2.04M |
|
292
Savara
SVRA
$1.16B
| $2.08M | 0.01% |
+651,137
| New | +$1.53M |
|
293
Bristol-Myers Squibb
BMY
$127B
| $2.06M | 0.01% |
32,267
-1,375
| -4% | -$92.2K |
|
294
GE Aerospace
GE
$371B
| $2.05M | 0.01% |
23,328
-5,995
| -20% | -$485K |
|
295
AT&T
T
$164B
| $2.02M | 0.01% |
126,766
-21,374
| -14% | -$364K |
|
296
ManpowerGroup
MAN
$2.43B
| $2.02M | 0.01% |
25,444
-7,181
| -22% | -$542K |
|
297
Vanguard Russell 1000 Value ETF
VONV
$20.5B
| $2M | 0.01% |
28,956
-1,809
| -6% | -$121K |
|
|
KKR.PRC
298
DELISTED
KKR & Co. Inc. 6.00% Series C Mandatory Convertible Preferred Stock
KKR.PRC
| $2M | 0.01% |
30,255
-3,000
| -9% | -$189K |
|
299
Intel
INTC
$485B
| $1.99M | 0.01% |
59,523
-2,565
| -4% | -$80.5K |
|
300
Hershey
HSY
$35.6B
| $1.99M | 0.01% |
7,965
-487
| -6% | -$128K |
|
Similar funds
SAM
First Manhattan's Q2 2023 Portfolio in Review
As of Q2 2023, First Manhattan held 1,588 positions worth $27.3B, up 4.7% from $26.1B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
First Manhattan withdrew a net $932M in Q2 2023, closing 161 positions and reducing 495 holdings. Its most notable exit was Enanta Pharmaceuticals, an estimated $10.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 45% a quarter earlier, followed by Technology and Healthcare.
Against the trend, First Manhattan opened a new position in Mersana Therapeutics worth $1.87M.
- First Manhattan's largest Q2 2023 buy was Mersana Therapeutics: 22,784 shares worth $1.87M.
- First Manhattan added most to Thermo Fisher Scientific in Q2 2023, an estimated $128M increase.
- First Manhattan's biggest Q2 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $760M.
- First Manhattan fully exited Enanta Pharmaceuticals in Q2 2023, selling an estimated $10.7M.
- First Manhattan's ten largest holdings make up 61% of its $27.3B portfolio in Q2 2023.
- First Manhattan opened 70 new positions and closed 161 in Q2 2023.
- First Manhattan's portfolio value rose 4.7% quarter-over-quarter to $27.3B.
Based on First Manhattan's 13F filing for Q2 2023, filed 14 Aug 2023.